Tower Research Capital LLC (Trc) Amgen Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Amgen Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 18,668 shares of AMGN stock, worth $6.38 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
18,668
Previous 11,711
59.41%
Holding current value
$6.38 Million
Previous $3.27 Million
61.15%
% of portfolio
0.16%
Previous 0.09%
Shares
33 transactions
Others Institutions Holding AMGN
# of Institutions
3,274Shares Held
428MCall Options Held
6.11MPut Options Held
5.85M-
Vanguard Group Inc Valley Forge, PA53.9MShares$18.4 Billion0.24% of portfolio
-
Black Rock Inc. New York, NY46MShares$15.7 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$10 Billion0.3% of portfolio
-
Capital International Investors Los Angeles, CA19.2MShares$6.56 Billion0.92% of portfolio
-
Capital World Investors Los Angeles, CA18.8MShares$6.42 Billion0.76% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $183B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...